Foundayo (Orforglipron)

Orforglipron is a medicine that helps adults with obesity or overweight lose weight and keep it off. It is a pill taken by mouth once a day. It works like the body's GLP-1 hormone, helping you feel full sooner so you eat less.

Brand names:Foundayo
Medication

What people taking Foundayo (Orforglipron) report

Every report comes from a Lived member, sent anonymously.

Have you tried Foundayo (Orforglipron) for Obesity?

NameHow it went

About Foundayo (Orforglipron)

What It's For

Orforglipron, sold in the US as Foundayo, is a once-daily prescription pill for long-term weight management. It is approved for adults with obesity, and for adults who are overweight and also have at least one weight-related health problem, such as high blood pressure, high cholesterol or sleep apnea. It is meant to be used alongside a reduced-calorie eating plan and more physical activity, not in place of them. Orforglipron belongs to the same family as the injectable GLP-1 medicines used for weight loss, but it is a tablet rather than a shot. It is not approved to treat type 2 diabetes itself, although it was studied for weight loss in adults who have type 2 diabetes. It is not approved for children or teenagers, and it should not be combined with another GLP-1 medicine.

How It Works

GLP-1 (glucagon-like peptide-1) is a hormone the body releases after eating. It signals to appetite centers in the brain that food has arrived, and it slows how quickly the stomach empties. Orforglipron activates the same GLP-1 receptor, so people tend to feel less hungry, feel full sooner and eat less. Over months, eating less leads to weight loss, and studies found that more of the weight lost was fat than muscle. Unlike the protein-based (peptide) GLP-1 medicines, orforglipron is a small, non-peptide molecule, and it is taken as an ordinary tablet.

Dosage & Administration

Foundayo is a tablet taken by mouth once a day, with or without food. Swallow it whole; do not break, crush or chew it, and do not take more than one tablet in a day. Treatment starts at the lowest strength, 0.8 mg, and steps up gradually: to 2.5 mg after at least 30 days, then to 5.5 mg after at least another 30 days. From there the prescriber may continue increasing, a step at a time and no faster than every 30 days, to 9 mg, 14.5 mg or the maximum of 17.2 mg, depending on how well it works and how well it is tolerated. The slow climb gives the digestive system time to adjust and reduces nausea and other stomach side effects. If a dose is missed, take it as soon as you remember, but never take two in the same day. If seven or more days in a row are missed, contact the prescriber before restarting, because the dose usually needs to drop back to a lower step.

Side Effects

Digestive side effects are the most common: nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, bloating, belching, heartburn and gas. In the main studies, about a third of people on the higher doses had nausea, compared with one in ten on placebo. These effects are most frequent while the dose is being increased and usually ease over time. Headache, tiredness and some hair loss also occurred more often than with placebo. About 8% of people stopped treatment because of side effects, most often stomach-related ones. Vomiting or diarrhea that does not let up can cause dehydration, which in some cases has damaged the kidneys. Drinking enough fluids helps, and nausea, vomiting or diarrhea that does not go away should be reported to the prescriber right away. A few less common problems need prompt attention. Severe stomach pain that will not go away, sometimes spreading to the back, can signal pancreatitis (inflammation of the pancreas): stop the medicine and call the prescriber right away. Pain in the upper stomach with fever, yellowing of the skin or eyes, or pale, clay-colored stools can point to a gallbladder problem, which becomes more likely with weight loss, and also warrants a prompt call. Swelling of the face, lips, tongue or throat, or trouble breathing or swallowing, may be a serious allergic reaction: stop the medicine and get emergency help right away.

Interactions & Warnings

Foundayo carries a boxed warning, the FDA's most prominent kind, about thyroid tumors. Medicines that act on the GLP-1 receptor caused thyroid C-cell tumors in rats and mice. Orforglipron does not act in those animals and did not cause tumors in them, and whether this risk applies to people is not known. Because of that uncertainty, it should not be used by anyone with a personal or family history of medullary thyroid carcinoma (a rare thyroid cancer) or with MEN 2 (multiple endocrine neoplasia type 2, an inherited condition that causes endocrine tumors). A lump or swelling in the neck, lasting hoarseness, trouble swallowing or shortness of breath should be reported to the prescriber. Several interactions matter in practice. Because orforglipron slows stomach emptying, birth control pills may be absorbed less reliably: people who use them are advised to switch to a non-pill method, or add a barrier method such as condoms, for 30 days after starting and for 30 days after each dose increase. People with diabetes who take insulin or a sulfonylurea (an older type of diabetes pill, such as glipizide) have a higher chance of low blood sugar, so those doses may need lowering. Some medicines change how much orforglipron reaches the blood, such as ritonavir (an HIV medicine), and the cholesterol medicine simvastatin should not exceed 20 mg a day alongside it. A pharmacist can check the full medication list, including supplements. Blood pressure can also drop, especially in people already taking blood pressure medicines. Tell the surgical or anesthesia team about orforglipron before any procedure that uses general anesthesia or deep sedation, because food left in a slowly emptying stomach can be inhaled into the lungs. Orforglipron should be stopped if pregnancy occurs, since weight loss offers no benefit during pregnancy and may harm the baby, and it is not recommended while breastfeeding. It is not recommended for people with severe gastroparesis (a condition in which the stomach empties very slowly) or severe liver disease. People with diabetic eye disease should have their eyes monitored, because rapid improvement in blood sugar can temporarily worsen it.

What to Expect

Weight loss builds gradually over months as the dose is stepped up. In the 72-week studies of adults without diabetes, people on the highest dose lost about 11% of their body weight on average, compared with about 2% on placebo, and around half lost at least 10%. Lower doses produced smaller losses, and people with type 2 diabetes lost somewhat less, about 10% at the highest dose versus 2.5% on placebo. These are averages; some people lose much more, and some lose little. Orforglipron is intended as a long-term treatment that works together with eating and activity changes. Follow-up visits are used to adjust the dose, check side effects and decide whether the benefit is worth continuing. Regular review of other medicines matters too, because weight loss can change what some people need for blood pressure or diabetes.

Questions to Ask Your Doctor

  1. 1.Is orforglipron a better fit for me than an injectable weight-loss medicine, and how do they compare in results and side effects?
  2. 2.How fast should we raise my dose, and what should I do if nausea or other stomach problems make a step hard to tolerate?
  3. 3.Do any of my current medicines, including birth control pills, cholesterol or diabetes medicines, need to change while I take this?
  4. 4.How much weight loss would make this worth continuing, and what is the plan if I eventually stop?
  5. 5.I have a procedure coming up. Do I need to do anything differently with orforglipron beforehand?

Last reviewed • Oct 2026

Educational content, not medical advice.